Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804479 · ClinicalTrials.gov registry record
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
A clinical trial, sponsored by University of Rochester.
- Terminated
- Registry status
- 222
- Enrollment target
NCT00804479 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 222 participants.
The verdict
NCT00804479 was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- 222 participants
- Enrollment target
Study Summary
To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole compared with levodopa will demonstrate less self-reported disability as measured by the Modified Schwab and England (S/E) scale 8 years after randomization.
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804479
The ClinicalTrials.gov registry entry for NCT00804479 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT00804479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804479 about?
NCT00804479 is a clinical study titled "The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)". To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole compared with levodopa will demonstrate less self-reported disability as measured by the Modified Schw...
What is the current status of trial NCT00804479?
This trial is currently terminated. The enrollment target is 222 participants. The study started on 2002-01. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00804479?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT00804479?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.